CSF proteogenomics implicates novel proteins and humoral immunity in Alzheimer's disease risk
Wingo, A. P.; Liu, Y.; Mei, Z.; Wang, M.; Vattathil, S. M.; Gerasimov, E. S.; Shantaraman, A.; Wu, F.; Duong, D. M.; Fox, E. J.; Alzheimer's Disease Neuroimaging Initiative, ; Bennett, D. A.; Levey, A. I.; Seyfried, N. T.; Wingo, T. S.
Show abstract
Identifying causal genes at Alzheimers Disease (AD) GWAS loci requires tissue-relevant functional genomic data. Cerebrospinal fluid (CSF) interfaces directly with the brain and can be obtained from living individuals, providing a potential proxy for brain protein biology at scale; however, large-scale CSF proteogenomic studies have been limited to affinity-based platforms. Here, we used mass spectrometry to profile CSF proteins in 1,005 participants measuring 2,961 proteins, including 1,066 proteins not captured by other platforms. We mapped protein quantitative trait loci (pQTLs) in CSF, compared them with brain and plasma pQTLs, and integrated them with AD GWAS results. We identified 1,417 cis and 130 trans pQTLs, and uncover 24 candidate causal proteins - 10 novel, including 5 detected only by mass spectrometry. These proteins implicate lysosomal function, neurovascular remodeling, and immune response. Notably, three immunoglobulins (IGHG2, IGHV2-70, IGHV3-72) link humoral immunity to AD risk for the first time.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Plasma p-tau212: antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology 96%
- DNA methylation signatures of Alzheimer's disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types 96%
- A public resource of single cell transcriptomes and multiscale networks from persons with and without Alzheimer's disease 96%
Similar papers in this journal
- Identification of a specific APOE transcript and functional elements associated with Alzheimer's disease 95%
- A Microglial Activity State Biomarker Panel Differentiates Ftd-Granulin And Ad From Control Cases 95%
- Multi-modal Proteomic Characterization of Lysosomal Function and Proteostasis in Progranulin-Deficient Neurons 94%
Similar papers in this journal
- Synapse protein signatures in cerebrospinal fluid and plasma predict cognitive maintenance versus decline in Alzheimers disease 96%
- Amyloid and Tau PET positive cognitively unimpaired individuals: Destined to decline? 92%
- Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations 92%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.